KinBio
Pharmaceuticals
Company Overview
Snapshot
Founded in November 2018, KinBio operates with 11–50 employees. The company ceased operations in January 2025.
Business overview
KinBio, a wholly-owned subsidiary of Hong Kong-based Gencor Pacific, specializes in the research, development, manufacturing, and global commercialization of biosimilars and biologics. The company focuses on creating generic versions of complex drugs and high-quality biosimilars to address diseases across various therapeutic areas, including CNS, inflammation, oncology, and osteoporosis. KinBio operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology.
Strategic signal
In January 2019, KinBio's parent company, Hong Kong-based Gencor Pacific, acquired the assets of the Israeli pharmaceutical company InSight Biopharmaceuticals. This acquisition provided KinBio with a foundation of technologies and assets, signaling a strategic move to build its portfolio in the biosimilars and biologics market by leveraging established pharmaceutical intellectual property.
Company Intelligence Q&A
- What is KinBio's primary focus in the pharmaceutical industry?
- KinBio is focused on developing a large portfolio of technologies for manufacturing generic versions of complex drugs, high-quality biosimilars, and biologics. The company specializes in research, development, manufacturing, and global commercialization of biosimilars to treat and prevent diseases across various therapeutic areas.
- Which therapeutic areas does KinBio target with its biosimilars?
- KinBio's biosimilars target several different therapeutic areas, including CNS, inflammation, oncology, and osteoporosis.
- What was a significant corporate event for KinBio in early 2019?
- In January 2019, KinBio's parent company, Hong Kong-based Gencor Pacific, acquired the assets of Israel-based pharmaceutical company InSight Biopharmaceuticals.
- What is KinBio's current operational status?
- KinBio ceased to operate in January 2025.
- Where is KinBio headquartered?
- KinBio is headquartered in Hong Kong.